- Home
- SURG vs ESLA Comparison
SURG vs ESLA Comparison
Compare SURG & ESLA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SURG
- ESLA
- Stock Information
- Founded
- SURG 2006
- ESLA 2021
- Country
- SURG United States
- ESLA United States
- Employees
- SURG N/A
- ESLA N/A
- Industry
- SURG Advertising
- ESLA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- SURG Consumer Discretionary
- ESLA Health Care
- Exchange
- SURG Nasdaq
- ESLA Nasdaq
- Market Cap
- SURG 35.9M
- ESLA 41.6M
- IPO Year
- SURG N/A
- ESLA N/A
- Fundamental
- Price
- SURG $1.58
- ESLA $1.14
- Analyst Decision
- SURG Buy
- ESLA
- Analyst Count
- SURG 2
- ESLA 0
- Target Price
- SURG $8.50
- ESLA N/A
- AVG Volume (30 Days)
- SURG 168.6K
- ESLA 15.7K
- Earning Date
- SURG 03-11-2025
- ESLA 02-12-2025
- Dividend Yield
- SURG N/A
- ESLA N/A
- EPS Growth
- SURG N/A
- ESLA N/A
- EPS
- SURG N/A
- ESLA N/A
- Revenue
- SURG $83,602,653.00
- ESLA N/A
- Revenue This Year
- SURG N/A
- ESLA N/A
- Revenue Next Year
- SURG $59.69
- ESLA N/A
- P/E Ratio
- SURG N/A
- ESLA N/A
- Revenue Growth
- SURG N/A
- ESLA N/A
- 52 Week Low
- SURG $1.33
- ESLA $0.63
- 52 Week High
- SURG $9.23
- ESLA $3.23
- Technical
- Relative Strength Index (RSI)
- SURG 40.66
- ESLA 48.91
- Support Level
- SURG $1.50
- ESLA $1.12
- Resistance Level
- SURG $1.75
- ESLA $1.27
- Average True Range (ATR)
- SURG 0.09
- ESLA 0.13
- MACD
- SURG -0.02
- ESLA -0.01
- Stochastic Oscillator
- SURG 21.62
- ESLA 40.40
About SURG SurgePays Inc.
Surgepays Inc is a fintech company focused on the underbanked community. It provides services to financial technology, telecommunications, and digital media companies. Its operating segment includes Mobile Virtual Network Operators that provide mobile broadband (internet connectivity), voice and SMS text messaging to both subsidized and direct retail prepaid customers through SurgePhone Wireless, LLC and Torch Wireless, LLC; Comprehensive Platform Services provide financial technology and a wireless top-up platform to independently owned convenience stores throughout the country; Lead Generation is a generation and case management solutions company serving law firms in the mass tort industry; and Others. It generates the revenue from Mobile Virtual Network Operator segment.
About ESLA Estrella Immunopharma Inc.
Estrella Immunopharma Inc is a clinical-stage biopharmaceutical company developing CD19 and CD22-targeted ARTEMIS T-cell therapies with the capacity to address treatment challenges for patients with blood cancers and solid tumors. Estrella's mission is to harness the evolutionary power of the human immune system to transform the lives of patients fighting cancer and autoimmune diseases.